ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China · Delayed Price · Currency is CNY 24.75
+0.83 (3.47%)
Last updated: Jul 16, 2025
ChengDa Pharmaceuticals Market Cap
ChengDa Pharmaceuticals has a market cap or net worth of 4.82 billion as of July 22, 2025. Its market cap has increased by 75.19% in one year.
Market Cap
4.82B
Enterprise Value
3.82B
Revenue
308.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.75
Market Cap Chart
Since January 20, 2022, ChengDa Pharmaceuticals's market cap has decreased from 12.43B to 4.82B, a decrease of -61.26%. That is a compound annual growth rate of -23.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2025 | 4.43B | 44.95% |
| Dec 31, 2024 | 3.06B | -22.31% |
| Dec 29, 2023 | 3.93B | -19.91% |
| Dec 30, 2022 | 4.91B | -60.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 391.84B |
| Shenzhen Mindray Bio-Medical Electronics | 272.50B |
| WuXi AppTec | 236.12B |
| Sichuan Biokin Pharmaceutical | 128.74B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.04B |
| Aier Eye Hospital Group | 116.29B |
| Shanghai United Imaging Healthcare | 104.88B |
| Yunnan Baiyao Group Co.,Ltd | 100.33B |